Brook Baker Professor of Law b.baker@northeastern.edu 617.373.3217 Expertise access to medicine, Community Health, COVID-19, critical perspectives on legal writing, cross-cultural lawyering, human rights, issues of legal skills, multiculturalism, theories of practice-based learning Brook K. Baker in the Press Abortion Pill, Vaccine Attacks Spell Trouble for FDA Approvals When it comes to distrust in FDA processes, it’s the agency’s activity during the US AIDS movement “that’s come back to haunt us a little bit,” said Brook Baker, a Northeastern University law professor. The Chronicle of Philanthropy Gates Foundation to Increase Funding to $8.3 Billion This Year The power the Seattle grant maker has over global health organizations concerns Brook Baker, a law professor at Northeastern University School of Law and senior analyst for the Health Global Access Project, an international advocacy organization that pushes to make HIV treatments available. Bloomberg Law Biden’s Omicron Booster Campaign Faces Fatigue, Efficacy Doubts “We are working against the tide of Covid fatigue, misinformation, and the government’s broken promises that the end is right around the corner,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP, an advocacy group focusing on equity in access to HIV medications. Bloomberg Law Moderna Patent Strike on Pfizer Sets Up Post-Covid Vaccine Feuds “Pfizer has know-how but should be rightly concerned about blocking patents on mRNA platform technologies,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP. ABC News WHO to share vaccines to stop monkeypox amid inequity fears “Just like with COVID, there is no clear path for how poorer countries will be able to get vaccines,” Brook Baker, a Northeastern University law professor who specializes in access to medicines, said. As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis “Both Merck and Pfizer have reserved for themselves all the high-income countries and virtually all of the upper-middle-income countries and even some lower-middle-income countries,” said Brook Baker, a law professor at Northeastern University who has submitted a legal brief in support of the Dominican Republic petition. Covid Booster Costs Spur Calls to Shift From Free Jabs for All (1) “The provision of vaccines on a long-term basis is probably going to devolve back to our fractured private and public sectors, instead of being paid for exclusively by the federal government,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP, an advocacy group focusing on […] Column: While we line up for a fourth shot, the world’s poor haven’t gotten their first “People in the U.S. have no greater right to health than people elsewhere in the world,” says Brook K. Baker, a Northeastern University Law School professor who specializes in access to medicines. “We’re all human. Health is a positive good for everyone. Yet we’re living under a monopoly-based system where giant pharmaceutical corporations make billions […] Nature News African clinical trial denied access to key COVID drug Paxlovid But Pfizer’s decision has dismayed public-health advocates. DNDi’s inability to obtain medicine for clinical trials compounds ongoing inequities in access to vaccines and treatments, including Paxlovid, in low- and middle-income countries, says Brook Baker, a law professor at Northeastern University in Boston, Massachusetts, who specializes in global access to medicines and vaccines. “This is a […] Salon Rich countries are getting the new COVID vaccine first “Whatever the explanation is, it’s unsatisfactory,” Brook Baker, an access to medicines specialist at Northeastern University, said in response to AP‘s reporting Thursday. “The bottom line is that there are still a lot of unvaccinated people in poor countries and once again, they are at the back of the line.” Brook K. Baker for Northeastern Global News Should pharmaceutical companies give up their patent protections to find a vaccine for COVID-19? Should pharmaceutical companies give up their patent protections to find a vaccine for COVID-19? The race for a COVID-19 vaccine is on, and public health officials are calling upon pharmaceutical companies to share their intellectual property—a move that could speed up research and make any eventual treatment more widely (and easily) available to the masses, says Northeastern law professor Brook Baker. Northeastern researchers examine the Zika pandemic Northeastern researchers examine the Zika pandemic As the Zika virus continues its inexorable spread, a panel of faculty members discussed how we can be part of the global solution. Remembering Nelson Mandela Remembering Nelson Mandela Northeastern faculty experts weigh in on Nelson Mandela’s life and legacy. 3Qs: High time for an AIDS ‘wake-up call’ 3Qs: High time for an AIDS ‘wake-up call’ Law professor Brook Baker, a featured speaker at the upcoming 2012 International AIDS Conference, evaluates how the global community is faring in the battle against AIDS.
Abortion Pill, Vaccine Attacks Spell Trouble for FDA Approvals When it comes to distrust in FDA processes, it’s the agency’s activity during the US AIDS movement “that’s come back to haunt us a little bit,” said Brook Baker, a Northeastern University law professor.
The Chronicle of Philanthropy Gates Foundation to Increase Funding to $8.3 Billion This Year The power the Seattle grant maker has over global health organizations concerns Brook Baker, a law professor at Northeastern University School of Law and senior analyst for the Health Global Access Project, an international advocacy organization that pushes to make HIV treatments available.
Bloomberg Law Biden’s Omicron Booster Campaign Faces Fatigue, Efficacy Doubts “We are working against the tide of Covid fatigue, misinformation, and the government’s broken promises that the end is right around the corner,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP, an advocacy group focusing on equity in access to HIV medications.
Bloomberg Law Moderna Patent Strike on Pfizer Sets Up Post-Covid Vaccine Feuds “Pfizer has know-how but should be rightly concerned about blocking patents on mRNA platform technologies,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP.
ABC News WHO to share vaccines to stop monkeypox amid inequity fears “Just like with COVID, there is no clear path for how poorer countries will be able to get vaccines,” Brook Baker, a Northeastern University law professor who specializes in access to medicines, said.
As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis “Both Merck and Pfizer have reserved for themselves all the high-income countries and virtually all of the upper-middle-income countries and even some lower-middle-income countries,” said Brook Baker, a law professor at Northeastern University who has submitted a legal brief in support of the Dominican Republic petition.
Covid Booster Costs Spur Calls to Shift From Free Jabs for All (1) “The provision of vaccines on a long-term basis is probably going to devolve back to our fractured private and public sectors, instead of being paid for exclusively by the federal government,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP, an advocacy group focusing on […]
Column: While we line up for a fourth shot, the world’s poor haven’t gotten their first “People in the U.S. have no greater right to health than people elsewhere in the world,” says Brook K. Baker, a Northeastern University Law School professor who specializes in access to medicines. “We’re all human. Health is a positive good for everyone. Yet we’re living under a monopoly-based system where giant pharmaceutical corporations make billions […]
Nature News African clinical trial denied access to key COVID drug Paxlovid But Pfizer’s decision has dismayed public-health advocates. DNDi’s inability to obtain medicine for clinical trials compounds ongoing inequities in access to vaccines and treatments, including Paxlovid, in low- and middle-income countries, says Brook Baker, a law professor at Northeastern University in Boston, Massachusetts, who specializes in global access to medicines and vaccines. “This is a […]
Salon Rich countries are getting the new COVID vaccine first “Whatever the explanation is, it’s unsatisfactory,” Brook Baker, an access to medicines specialist at Northeastern University, said in response to AP‘s reporting Thursday. “The bottom line is that there are still a lot of unvaccinated people in poor countries and once again, they are at the back of the line.”